pamidronate has been researched along with Adenocarcinoma Of Kidney in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate is a second generation bisphosphonate used for treating tumor-induced hypercalcemia and for preventing the development of new bone metastasis." | 7.69 | [Effect of pamidronate and interferon-alpha on bone and lung metastases and hypercalcemia in a patient with renal cell carcinoma]. ( Arima, K; Hioki, T; Kawamura, J; Kise, H; Kobayashi, K; Sugiura, Y; Tochigi, H; Yanagawa, M, 1996) |
| "Pamidronate is a second generation bisphosphonate used for treating tumor-induced hypercalcemia and for preventing the development of new bone metastasis." | 3.69 | [Effect of pamidronate and interferon-alpha on bone and lung metastases and hypercalcemia in a patient with renal cell carcinoma]. ( Arima, K; Hioki, T; Kawamura, J; Kise, H; Kobayashi, K; Sugiura, Y; Tochigi, H; Yanagawa, M, 1996) |
| "We report a renal cell carcinoma case in which multiple lung and bone metastases displayed remarkable remission to BP therapy using 30 mg pamidronate once, 4 mg zoledronate once, and weekly 10 mg incadronate 10 times for 3 months." | 1.35 | Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report. ( Fujii, Y; Fukui, I; Kijima, T; Okubo, Y; Suyama, T; Yonese, J, 2008) |
| "Zoledronic acid was consistently more potent than pamidronate for inducing apoptotic cell death." | 1.33 | Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines. ( Anderson, C; Birchall, L; Harrington, K; Meyer, B; Pandha, H; Relph, K; Wilson, N, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKay, RR | 1 |
| Lin, X | 1 |
| Perkins, JJ | 1 |
| Heng, DY | 1 |
| Simantov, R | 1 |
| Choueiri, TK | 1 |
| Pandha, H | 1 |
| Birchall, L | 1 |
| Meyer, B | 1 |
| Wilson, N | 1 |
| Relph, K | 1 |
| Anderson, C | 1 |
| Harrington, K | 1 |
| Kijima, T | 1 |
| Fujii, Y | 1 |
| Suyama, T | 1 |
| Okubo, Y | 1 |
| Yonese, J | 1 |
| Fukui, I | 1 |
| Kise, H | 1 |
| Kobayashi, K | 1 |
| Arima, K | 1 |
| Yanagawa, M | 1 |
| Tochigi, H | 1 |
| Kawamura, J | 1 |
| Hioki, T | 1 |
| Sugiura, Y | 1 |
| Akbulut, H | 1 |
| Icli, F | 1 |
| Morton, AR | 1 |
| Friefeld, J | 1 |
| Halperin, F | 1 |
6 other studies available for pamidronate and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma.
Topics: Aged; Antineoplastic Agents; Axitinib; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Dens | 2014 |
Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cell Prolifer | 2006 |
Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imi | 2008 |
[Effect of pamidronate and interferon-alpha on bone and lung metastases and hypercalcemia in a patient with renal cell carcinoma].
Topics: Antineoplastic Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Hypercalcemia; | 1996 |
Overdosage of pamidronate in a patient with renal cell carcinoma.
Topics: Aged; Anti-Inflammatory Agents; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Hypercalcemia | 2000 |
Dose of bisphosphonate for hypercalcaemia of malignancy.
Topics: Aged; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; | 1990 |